HLOSF(HLOSF)
HLOSF
11/5/26
Healios K.K. (HLOSF)
Thursday
10:30 AM
ThesisRecent competitive pressures and ongoing cash flow challenges have raised concerns about Healios' ability to sustain its operations and market position.
Revenue Outlook
What Moves the Stock
- 01Regulatory approvals for new therapies, particularly in Japan and the US
- 02Partnership announcements with major pharmaceutical companies
- 03Clinical trial results for lead products
- 04Market adoption rates of existing therapies
- 05Cell therapy products - 70%
- 06Research collaborations - 30%
- 07Regenerative medicine advancements
- 08Increased investment in biotechnology R&D
FY2025 Snapshot
- Revenue
- $104M
- Rev. Growth
- -81.4%
- Gross Margin
- -374%
- Op. Margin
- -3272%
- Net Margin
- -2132%
- Net Income
- $-2.2B
- NI Growth
- +47.6%
- EPS
- $-20.59
- 1Y Return
- -47.1%
HLOSF Chart
My Notes
- "The market is increasingly questioning our path to profitability amidst rising competition."
- Moat: Healios has a moderate moat due to its proprietary technology and established partnerships, but faces significant competitive threats.
- growth - Investors are likely attracted to the potential for high returns from innovative therapies, despite current losses.
- Interest rates can impact Healios by affecting the cost of financing for R&D and operational expenses…
- Watch on earnings: Clinical trial enrollment rates, Regulatory approval timelines, Partnership revenue contributions.
One Sentence Summary:
Healios K.K.: the story is balanced — regulatory approvals for new therapies, particularly in japan and the us.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
Explore More
HLOSF Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
